Printer Friendly

Bristol-Myers Squibb names new director.

M2 PHARMA-September 18, 2017-Bristol-Myers Squibb names new director

(C)2017 M2 COMMUNICATIONS

United States-based Bristol-Myers Squibb has named Cancer Research UK's Karen Vousden as its director effective January 2017, it is reported today.

Presently, Vousden is the chief scientist at Cancer Research UK and is serving as group leader at the Francis Crick Institute in London and will also sit the pharma firm's Science and Technology Committee. She has more than 30 years' experience in cancer research and her earlier roles included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.

Giovanni Caforio, BMS' chairman and chief executive officer, said, 'Karen is a world class cancer researcher and a highly accomplished leader in her field. Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.'

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Geographic Code:4EUUK
Date:Sep 18, 2017
Words:163
Previous Article:Edstrom Industries completes combination with Triple Red.
Next Article:James Cardia to Manage Business Development and Partnering at RXi Pharmaceuticals with Departure of Chief Business Officer Eliseev.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters